Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Novartis takes the hot seat in China corruption probe

Chinese officials say they're stepping up their pharma investigation even further.

China sales rep says Novartis ordered her to bribe doctors

Big Pharma, beware of your former (and possibly current) employees in China. Novartis is the latest drugmaker to be fingered for bribery by an anonymous whistleblower, just a few days after Sanofi got the same treatment. And Chinese officials say they're stepping up their pharma investigation even further.

How did Israel become a hotbed for medical devices?

Israel is home to nearly 700 medical device outfits, with companies in all of the industry's in-demand markets. So how did a country about the size of New Jersey with roughly the population of Virginia become a go-to medical technology breeding ground?

Pharmstandard's $590M Bever buy beefs up OTC unit for spinoff

Russia's Pharmstandard is clearing the way for a proposed spinoff of its over-the-counter drugs unit--and clarifying the details for some skeptical investors.

Mylan geared up for big expansion in India

Mylan has boosted manufacturing in India significantly in the 7 years it has been a player there, and wants Indian authorities to understand that much of its further expansion of production will be focused the Indian market.

India's Aurobindo buys, boosts sterile capacity

India's Aurobindo Pharma sees the sterile injectable business as being a growing part of its revenues and over the next couple of years expects to nearly quadruple capacity at one new unit, even as it buys some additional capacity.

Russia's Pharmstandard still weighing OTC unit sale, exec says

In late June, Russia's Pharmstandard was reportedly considering a sale of its OTC business. A couple of weeks later, the company said it would spin the unit off instead. But the fate of that business is still up in the air, with a sale to another drugmaker still a possibility, Chairman Viktor Kharitonin tells  Bloomberg.

Montreal's EMcision launches catheters for pancreatic cancer

Canadian devicemaker EMcision International has sold the first units of its pancreatic tumor ablation catheter, the Habib RF Duo 13, in Europe and China, notching a foothold to gain further insight into the device's efficacy.

Icon signs up to boost Taiwan's stake in drug development

CRO Icon has signed a deal with the National Taiwan University Hospital, lending its weight in clinical research to help make local trials faster and more reliable.

Sanofi 'confident' about China ops as officials launch bribery probe

Sanofi has joined GlaxoSmithKline under China's official corruption microscope. According to the state news service Xinhua, authorities are investigating allegations that the French drugmaker bribed more than 500 doctors.